198 related articles for article (PubMed ID: 12689746)
41. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
[TBL] [Abstract][Full Text] [Related]
42. Analysis of clozapine and norclozapine by high-performance liquid chromatography.
Akerman KK
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):253-9. PubMed ID: 9323545
[TBL] [Abstract][Full Text] [Related]
43. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
Perry PJ; Miller DD; Arndt SV; Cadoret RJ
Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
[TBL] [Abstract][Full Text] [Related]
44. Plasma clozapine concentration coefficients of variation in a long-term study.
Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
[TBL] [Abstract][Full Text] [Related]
45. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
[TBL] [Abstract][Full Text] [Related]
46. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Volpicelli SA; Centorrino F; Puopolo PR; Kando J; Frankenburg FR; Baldessarini RJ; Flood JG
Clin Chem; 1993 Aug; 39(8):1656-9. PubMed ID: 8353952
[TBL] [Abstract][Full Text] [Related]
47. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.
Nordin C; Almé B; Bondesson U
Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524
[TBL] [Abstract][Full Text] [Related]
48. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
49. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.
Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ
J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609
[TBL] [Abstract][Full Text] [Related]
50. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.
Rostami-Hodjegan A; Amin AM; Spencer EP; Lennard MS; Tucker GT; Flanagan RJ
J Clin Psychopharmacol; 2004 Feb; 24(1):70-8. PubMed ID: 14709950
[TBL] [Abstract][Full Text] [Related]
51. Clozapine dosages and plasma drug concentrations.
Chang WH; Lin SK; Lane HY; Hu WH; Jann MW; Lin HN
J Formos Med Assoc; 1997 Aug; 96(8):599-605. PubMed ID: 9290269
[TBL] [Abstract][Full Text] [Related]
52. Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
Flanagan RJ; Hunter S; Obee SJ
J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):514-519. PubMed ID: 37930204
[TBL] [Abstract][Full Text] [Related]
53. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
54. Determination of clozapine and its metabolite, N-desmethylclozapine, in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats.
Ma F; Lau CE
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):193-8. PubMed ID: 9698242
[TBL] [Abstract][Full Text] [Related]
55. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine.
Buur-Rasmussen B; Brøsen K
Eur Neuropsychopharmacol; 1999 Dec; 9(6):453-9. PubMed ID: 10625111
[TBL] [Abstract][Full Text] [Related]
56. The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method.
Kamil Gharab KM; Onmaz DE; Abusoglu S; Aydin M; Sivrikaya A; Tok O; Abusoglu G; Unlu A
J Pharm Biomed Anal; 2020 Feb; 180():113056. PubMed ID: 31887669
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high-performance liquid chromatography with ultraviolet detection.
Liu YY; van Troostwijk LJ; Guchelaar HJ
Biomed Chromatogr; 2001 Jun; 15(4):280-6. PubMed ID: 11438972
[TBL] [Abstract][Full Text] [Related]
58. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010.
Bowskill S; Couchman L; MacCabe JH; Flanagan RJ
Hum Psychopharmacol; 2012 May; 27(3):277-83. PubMed ID: 22419536
[TBL] [Abstract][Full Text] [Related]
59. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Fisher DS; Partridge SJ; Handley SA; Couchman L; Morgan PE; Flanagan RJ
Forensic Sci Int; 2013 Jun; 229(1-3):145-50. PubMed ID: 23477803
[TBL] [Abstract][Full Text] [Related]
60. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets.
Flanagan RJ; Hunter S; Obee SJ; Reeves S
J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):400-404. PubMed ID: 35652731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
